NURS 6630 MIDTERM EXAM 4 –
PSYCHOPHARMACOLOGY ACTUAL EXAM
Complete Question and Answers – Graduate-Level
Psychiatric Mental Health Nurse Practitioner – Pass
Guaranteed - A+ Graded
Neurobiology & Pharmacodynamics Foundations
Q1: A PMHNP is explaining the mechanism of action of a benzodiazepine to a nursing
student. The instructor describes the drug as binding to a site on the GABA-A receptor
to increase the frequency of chloride channel opening. Which of the following terms best
describes this mechanism?
A. Competitive antagonist
B. Negative allosteric modulator
C. Positive allosteric modulator [CORRECT]
D. Non-competitive inverse agonist
Correct Answer: C
Rationale: Benzodiazepines do not open the chloride channel themselves but bind to a
specific site to make GABA more efficient at doing so; this is the definition of a positive
allosteric modulator.
Q2: When considering the blood-brain barrier (BBB), which property must a medication
possess to easily pass from the systemic circulation into the central nervous system?
A. High ionization at physiological pH
B. Lipophilicity [CORRECT]
C. Large molecular weight
D. High protein binding to albumin
Correct Answer: B
Rationale: The BBB is highly selective, allowing lipid-soluble (lipophilic) molecules to
passively diffuse across endothelial cell membranes much more easily than
water-soluble or large, ionized molecules.
Q3: A 45-year-old patient with Parkinson’s disease demonstrates a resting tremor and
bradykinesia. These symptoms are primarily associated with the degeneration of
dopamine neurons in which specific pathway?
A. Mesolimbic pathway
,B. Nigrostriatal pathway [CORRECT]
C. Tuberoinfundibular pathway
D. Mesocortical pathway
Correct Answer: B
Rationale: The nigrostriatal pathway projects from the substantia nigra to the basal
ganglia and is crucial for motor control; its degeneration leads to the motor symptoms
seen in Parkinson’s disease.
Q4: A patient is prescribed a medication that acts as a partial agonist at the dopamine
D2 receptor. The PMHNP understands that this drug will:
A. Fully activate the receptor to its maximum effect
B. Block the receptor completely regardless of endogenous dopamine levels
C. Produce a submaximal response even when all receptors are occupied [CORRECT]
D. Have no effect on the receptor but prevent dopamine binding
Correct Answer: C
Rationale: Partial agonists bind to the receptor and activate it, but they produce a
response that is less than the maximum effect produced by a full agonist (like
endogenous dopamine).
Q5: Which second messenger system is primarily activated by the stimulation of
beta-adrenergic receptors, leading to the conversion of ATP to cAMP?
A. Phosphoinositide system
B. Tyrosine kinase system
C. Adenylyl cyclase system [CORRECT]
D. Ionotropic channel system
Correct Answer: C
Rationale: Stimulation of Gs-coupled receptors like beta-adrenergic receptors activates
adenylyl cyclase, which converts ATP to cyclic AMP (cAMP), a common second
messenger.
Q6: The PMHNP is treating a patient with schizophrenia who experiences negative
symptoms (blunted affect, avolition). Dysfunction in which dopamine pathway is most
strongly implicated in these symptoms?
A. Mesocortical pathway [CORRECT]
B. Nigrostriatal pathway
C. Mesolimbic pathway
D. Tuberoinfundibular pathway
Correct Answer: A
Rationale: Hypodopaminergia in the mesocortical pathway (projection to the prefrontal
cortex) is the primary neurobiological theory explaining the negative symptoms and
cognitive deficits of schizophrenia.
, Q7: A patient asks how their antidepressant medication works. The practitioner explains
that while the immediate effect is increasing synaptic serotonin, the therapeutic effect
likely involves downstream changes such as increased expression of Brain-Derived
Neurotrophic Factor (BDNF). This process is an example of:
A. Acute receptor antagonism
B. Reuptake inhibition
C. Neural plasticity [CORRECT]
D. Blood-brain barrier degradation
Correct Answer: C
Rationale: The timeline of antidepressant efficacy suggests that while reuptake
inhibition is immediate, the clinical improvement relies on slower adaptive changes,
including synaptic remodeling and increased BDNF, which constitute neural plasticity.
Q8: Glutamate is the primary excitatory neurotransmitter in the CNS. Which receptor
type is specifically linked to learning and memory through its involvement in long-term
potentiation (LTP) and is also a target of the dissociative drug ketamine?
A. AMPA receptor
B. Kainate receptor
C. NMDA receptor [CORRECT]
D. Metabotropic glutamate receptor 5
Correct Answer: C
Rationale: The NMDA receptor is crucial for synaptic plasticity, long-term potentiation
(LTP), and memory formation; ketamine acts as an NMDA receptor antagonist to
produce rapid antidepressant effects.
Q9: A patient on long-term antipsychotic therapy develops galactorrhea and
amenorrhea. This adverse effect is caused by dopamine blockade in which pathway?
A. Mesolimbic pathway
B. Mesocortical pathway
C. Nigrostriatal pathway
D. Tuberoinfundibular pathway [CORRECT]
Correct Answer: D
Rationale: The tuberoinfundibular pathway regulates prolactin secretion; dopamine
normally inhibits prolactin, so blockade here causes hyperprolactinemia leading to
galactorrhea and menstrual irregularities.
Q10: A medication is described as having "high affinity" for a receptor. This means that:
A. The drug will produce a strong physiological response at that receptor.
B. The drug will bind tightly to the receptor, but may not activate it. [CORRECT]
C. The drug requires a high concentration to bind to the receptor.
D. The drug has a low potential for side effects.
PSYCHOPHARMACOLOGY ACTUAL EXAM
Complete Question and Answers – Graduate-Level
Psychiatric Mental Health Nurse Practitioner – Pass
Guaranteed - A+ Graded
Neurobiology & Pharmacodynamics Foundations
Q1: A PMHNP is explaining the mechanism of action of a benzodiazepine to a nursing
student. The instructor describes the drug as binding to a site on the GABA-A receptor
to increase the frequency of chloride channel opening. Which of the following terms best
describes this mechanism?
A. Competitive antagonist
B. Negative allosteric modulator
C. Positive allosteric modulator [CORRECT]
D. Non-competitive inverse agonist
Correct Answer: C
Rationale: Benzodiazepines do not open the chloride channel themselves but bind to a
specific site to make GABA more efficient at doing so; this is the definition of a positive
allosteric modulator.
Q2: When considering the blood-brain barrier (BBB), which property must a medication
possess to easily pass from the systemic circulation into the central nervous system?
A. High ionization at physiological pH
B. Lipophilicity [CORRECT]
C. Large molecular weight
D. High protein binding to albumin
Correct Answer: B
Rationale: The BBB is highly selective, allowing lipid-soluble (lipophilic) molecules to
passively diffuse across endothelial cell membranes much more easily than
water-soluble or large, ionized molecules.
Q3: A 45-year-old patient with Parkinson’s disease demonstrates a resting tremor and
bradykinesia. These symptoms are primarily associated with the degeneration of
dopamine neurons in which specific pathway?
A. Mesolimbic pathway
,B. Nigrostriatal pathway [CORRECT]
C. Tuberoinfundibular pathway
D. Mesocortical pathway
Correct Answer: B
Rationale: The nigrostriatal pathway projects from the substantia nigra to the basal
ganglia and is crucial for motor control; its degeneration leads to the motor symptoms
seen in Parkinson’s disease.
Q4: A patient is prescribed a medication that acts as a partial agonist at the dopamine
D2 receptor. The PMHNP understands that this drug will:
A. Fully activate the receptor to its maximum effect
B. Block the receptor completely regardless of endogenous dopamine levels
C. Produce a submaximal response even when all receptors are occupied [CORRECT]
D. Have no effect on the receptor but prevent dopamine binding
Correct Answer: C
Rationale: Partial agonists bind to the receptor and activate it, but they produce a
response that is less than the maximum effect produced by a full agonist (like
endogenous dopamine).
Q5: Which second messenger system is primarily activated by the stimulation of
beta-adrenergic receptors, leading to the conversion of ATP to cAMP?
A. Phosphoinositide system
B. Tyrosine kinase system
C. Adenylyl cyclase system [CORRECT]
D. Ionotropic channel system
Correct Answer: C
Rationale: Stimulation of Gs-coupled receptors like beta-adrenergic receptors activates
adenylyl cyclase, which converts ATP to cyclic AMP (cAMP), a common second
messenger.
Q6: The PMHNP is treating a patient with schizophrenia who experiences negative
symptoms (blunted affect, avolition). Dysfunction in which dopamine pathway is most
strongly implicated in these symptoms?
A. Mesocortical pathway [CORRECT]
B. Nigrostriatal pathway
C. Mesolimbic pathway
D. Tuberoinfundibular pathway
Correct Answer: A
Rationale: Hypodopaminergia in the mesocortical pathway (projection to the prefrontal
cortex) is the primary neurobiological theory explaining the negative symptoms and
cognitive deficits of schizophrenia.
, Q7: A patient asks how their antidepressant medication works. The practitioner explains
that while the immediate effect is increasing synaptic serotonin, the therapeutic effect
likely involves downstream changes such as increased expression of Brain-Derived
Neurotrophic Factor (BDNF). This process is an example of:
A. Acute receptor antagonism
B. Reuptake inhibition
C. Neural plasticity [CORRECT]
D. Blood-brain barrier degradation
Correct Answer: C
Rationale: The timeline of antidepressant efficacy suggests that while reuptake
inhibition is immediate, the clinical improvement relies on slower adaptive changes,
including synaptic remodeling and increased BDNF, which constitute neural plasticity.
Q8: Glutamate is the primary excitatory neurotransmitter in the CNS. Which receptor
type is specifically linked to learning and memory through its involvement in long-term
potentiation (LTP) and is also a target of the dissociative drug ketamine?
A. AMPA receptor
B. Kainate receptor
C. NMDA receptor [CORRECT]
D. Metabotropic glutamate receptor 5
Correct Answer: C
Rationale: The NMDA receptor is crucial for synaptic plasticity, long-term potentiation
(LTP), and memory formation; ketamine acts as an NMDA receptor antagonist to
produce rapid antidepressant effects.
Q9: A patient on long-term antipsychotic therapy develops galactorrhea and
amenorrhea. This adverse effect is caused by dopamine blockade in which pathway?
A. Mesolimbic pathway
B. Mesocortical pathway
C. Nigrostriatal pathway
D. Tuberoinfundibular pathway [CORRECT]
Correct Answer: D
Rationale: The tuberoinfundibular pathway regulates prolactin secretion; dopamine
normally inhibits prolactin, so blockade here causes hyperprolactinemia leading to
galactorrhea and menstrual irregularities.
Q10: A medication is described as having "high affinity" for a receptor. This means that:
A. The drug will produce a strong physiological response at that receptor.
B. The drug will bind tightly to the receptor, but may not activate it. [CORRECT]
C. The drug requires a high concentration to bind to the receptor.
D. The drug has a low potential for side effects.
